Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Matzneller

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|October 21, 2011
Antimicrobial effect of statins: organic solvents might falsify microbiological testing resultsP Matzneller, M Manafi, M Zeitlinger
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2015
Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth mediaP Matzneller, S Strommer, Z Österreicher, et al.
Journal of Internal Medicine|October 30, 2019
PCSK9 decreases during experimental endotoxemiaC Schoergenhofer, P Matzneller, J Mühlbacher, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapyP Matzneller, S Krasniqi, M Kinzig, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapyS Krasniqi, P Matzneller, M Kinzig, et al.
Clinical Pharmacology and Therapeutics|November 20, 2016
Colistin Reduces LPS-Triggered Inflammation in a Human Sepsis Model In Vivo: A Randomized Controlled TrialP Matzneller, S Strommer, C Drucker, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentrationI Leitner, J Nemeth, T Feurstein, et al.
The Journal of Antimicrobial Chemotherapy|January 10, 2016
Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluidM Zeitlinger, R Schwameis, A Burian, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2021
Plasma and soft tissue pharmacokinetics of ceftolozane/tazobactam in healthy volunteers after single and multiple intravenous infusion: a microdialysis studyV Al Jalali, M Wölfl-Duchek, M Taubert, et al.
Scientific Reports|July 23, 2016
Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humansB Thaler, P J Hohensinner, K A Krychtiuk, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Clinical Pharmacology and Therapeutics|October 21, 2011
Antimicrobial effect of statins: organic solvents might falsify microbiological testing resultsP Matzneller, M Manafi, M Zeitlinger
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2015
Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth mediaP Matzneller, S Strommer, Z Österreicher, et al.
Journal of Internal Medicine|October 30, 2019
PCSK9 decreases during experimental endotoxemiaC Schoergenhofer, P Matzneller, J Mühlbacher, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapyP Matzneller, S Krasniqi, M Kinzig, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapyS Krasniqi, P Matzneller, M Kinzig, et al.
Clinical Pharmacology and Therapeutics|November 20, 2016
Colistin Reduces LPS-Triggered Inflammation in a Human Sepsis Model In Vivo: A Randomized Controlled TrialP Matzneller, S Strommer, C Drucker, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentrationI Leitner, J Nemeth, T Feurstein, et al.
The Journal of Antimicrobial Chemotherapy|January 10, 2016
Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluidM Zeitlinger, R Schwameis, A Burian, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2021
Plasma and soft tissue pharmacokinetics of ceftolozane/tazobactam in healthy volunteers after single and multiple intravenous infusion: a microdialysis studyV Al Jalali, M Wölfl-Duchek, M Taubert, et al.
Scientific Reports|July 23, 2016
Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humansB Thaler, P J Hohensinner, K A Krychtiuk, et al.
Pageof 2